Detalhe da pesquisa
1.
Meropenem-ANT3310, a unique ß-lactam-ß-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii.
Antimicrob Agents Chemother
; 68(3): e0112023, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289044
2.
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy-SMART 2017-2021.
Eur J Clin Microbiol Infect Dis
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775873
3.
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland-SMART 2017-2020.
Eur J Clin Microbiol Infect Dis
; 42(3): 365-370, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670243
4.
In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843997
5.
In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843999
6.
In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014-2015.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30988152
7.
In Vitro Activity of Iclaprim against Isolates in Two Phase 3 Clinical Trials (REVIVE-1 and -2) for Acute Bacterial Skin and Skin Structure Infections.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642922
8.
Activity of imipenem/relebactam against MDR Pseudomonas aeruginosa in Europe: SMART 2015-17.
J Antimicrob Chemother
; 74(8): 2284-2288, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31086960
9.
In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.
J Antimicrob Chemother
; 73(7): 1872-1879, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29659861
10.
Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate microspheres.
Eur J Clin Microbiol Infect Dis
; 37(4): 673-678, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29222698
11.
In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study.
Can J Infect Dis Med Microbiol
; 2017: 3948626, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29527229
12.
Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates.
J Glob Antimicrob Resist
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723712
13.
In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020.
J Glob Antimicrob Resist
; 33: 304-320, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207925
14.
In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.
Antibiotics (Basel)
; 12(7)2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37508192
15.
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020.
Int J Antimicrob Agents
; 61(5): 106772, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878411
16.
In vitro activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa collected from patients with bloodstream, intra-abdominal and urinary tract infections in Western Europe: SMART 2018-2020.
J Med Microbiol
; 72(2)2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763081
17.
In vitro activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa collected from patients with lower respiratory tract infections in Western Europe: SMART 2018-20.
JAC Antimicrob Resist
; 5(1): dlad003, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36694850
18.
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)-SMART 2017-21.
JAC Antimicrob Resist
; 5(4): dlad098, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577157
19.
Using nucleic acid microarrays to perform molecular epidemiology and detect novel ß-lactamases: a snapshot of extended-spectrum ß-lactamases throughout the world.
J Clin Microbiol
; 50(5): 1632-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22322349
20.
Surveillance programmes and antibiotic resistance: worldwide and regional monitoring of antibiotic resistance trends.
Handb Exp Pharmacol
; (211): 31-43, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23090594